GlassScriptPhysician profile
Nam H Le
NPI 1952518656
$467.02
in general payments reported to CMS, 2019-2025
8 companies · $60.44 in 2025
The $60.44 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $59.06 · 2021: $39.65 · 2022: $22.56 · 2023: $45.32 · 2024: $120 · 2025: $60.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $139.96 | 2021-2024 | Swanson, Dart-Fire, Variax |
| Pylant Medical | $89.68 | 2019-2025 | |
| Integra Lifesciences Corporation | $85.58 | 2019-2020 | |
| Smith+Nephew, INC. | $65.17 | 2021-2023 | Vlp Mini-Mod, Evos Mini |
| Pacira Pharmaceuticals Incorporated | $27.64 | 2020 | |
| Zimmer Biomet Holdings, INC. | $26.19 | 2019 | |
| Amgen INC. | $17.30 | 2025 | Krystexxa |
| Linvatec Corporation | $15.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nam Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.